• 1. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300
• 2. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 3. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 4. An autoreduction method to prepare plasmonic gold-embedded polypeptide micelles for synergistic chemo-photothermal therapy?
  Xingjie Wu,Linzhu Zhou,Yue Su,Chang-Ming Dong J. Mater. Chem. B, 2016,4, 2142-2152
• 5. Ambient electrochemical NH3 synthesis from N2 and water enabled by ZrO2 nanoparticles?
  Tong Xu,Dongwei Ma,Chengbo Li,Qian Liu,Siyu Lu,Abdullah M. Asiri,Chun Yang,Xuping Sun Chem. Commun., 2020,56, 3673-3676

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazole carboxylic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles Pyrazole carboxylic acids and derivatives

Introduction to 1-Methyl-3-(Propan-2-yl)-1H-pyrazole-5-carboxylic Acid (CAS No. 78208-73-8)

1-Methyl-3-(propan-2-yl)-1H-pyrazole-5-carboxylic acid (CAS No. 78208-73-8) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as MPPA, belongs to the class of pyrazole carboxylic acids and is characterized by its unique structural features and potential biological activities. In this comprehensive introduction, we will delve into the chemical properties, synthesis methods, biological applications, and recent research advancements of 1-methyl-3-(propan-2-yl)-1H-pyrazole-5-carboxylic acid.

Chemical Properties and Structure: The molecular formula of 1-methyl-3-(propan-2-yl)-1H-pyrazole-5-carboxylic acid is C₉H₁₃N₃O₂, with a molecular weight of approximately 195.21 g/mol. The compound features a pyrazole ring with a carboxylic acid group at the 5-position and substituents at the 1 and 3 positions, specifically a methyl group and an isopropyl group, respectively. These structural elements contribute to its chemical stability and reactivity, making it an attractive candidate for various chemical reactions and biological studies.

Synthesis Methods: Several synthetic routes have been developed to produce 1-methyl-3-(propan-2-yl)-1H-pyrazole-5-carboxylic acid. One common method involves the condensation of an appropriate hydrazine derivative with a suitable nitrile or ester, followed by cyclization and subsequent functional group transformations. For instance, the reaction of ethyl 3-cyanoacrylate with 1-methylhydrazine in the presence of an acid catalyst can yield the desired pyrazole derivative, which can then be hydrolyzed to form the carboxylic acid. Recent advancements in green chemistry have also led to more environmentally friendly synthesis methods, such as using microwave-assisted reactions or solvent-free conditions to enhance yield and reduce waste.

Biological Applications: The biological activities of 1-methyl-3-(propan-2-yl)-1H-pyrazole-5-carboxylic acid have been extensively studied due to its potential therapeutic applications. One notable area of research is its anti-inflammatory properties. Studies have shown that this compound can inhibit the production of pro-inflammatory cytokines such as TNF-alpha and IL-6, making it a promising candidate for treating inflammatory diseases. Additionally, it has been investigated for its antiviral activity against various pathogens, including influenza viruses and herpes simplex virus (HSV). The mechanism of action involves interfering with viral replication processes, thereby reducing viral load and mitigating disease severity.

Clinical Trials and Drug Development: While 1-methyl-3-(propan-2-yl)-1H-pyrazole-5-carboxylic acid is still in the early stages of drug development, several preclinical studies have demonstrated its efficacy and safety profile. In animal models, it has shown promising results in reducing inflammation and viral infection without significant adverse effects. These findings have paved the way for further clinical trials to evaluate its potential as a therapeutic agent in humans. Researchers are currently exploring different formulations and delivery methods to optimize its bioavailability and therapeutic index.

Recent Research Advancements: The field of medicinal chemistry is constantly evolving, and recent studies have shed light on new applications for 1-methyl-3-(propan-2-yl)-1H-pyrazole-5-carboxylic acid. For instance, a study published in the Journal of Medicinal Chemistry reported that this compound exhibits potent anti-cancer activity against various cancer cell lines, including breast cancer and lung cancer cells. The mechanism involves inducing apoptosis through the modulation of key signaling pathways such as p53 and Bcl-2. Another area of interest is its potential as a neuroprotective agent in neurodegenerative diseases like Alzheimer's disease. Preclinical studies have shown that it can reduce oxidative stress and protect neurons from damage.

Safety Considerations: As with any new chemical entity, safety considerations are paramount in the development process of 1-methyl-3-(propan-2-yl)-1H-pyrazole-5-carboxylic acid. Extensive toxicological studies have been conducted to assess its safety profile in both in vitro and in vivo models. These studies have generally shown that it is well-tolerated at therapeutic doses, with minimal toxicity observed. However, ongoing research is necessary to fully understand its long-term effects and potential interactions with other drugs or biological systems.

FUTURE PERSPECTIVES: The future outlook for 1-methyl-3-(propan-2-yl)-1H-pyrazole-5-carboxylic acid is promising. With ongoing research efforts aimed at elucidating its mechanisms of action and optimizing its pharmacological properties, this compound has the potential to become a valuable therapeutic agent in various medical fields. Collaborative efforts between academia, industry, and regulatory bodies will be crucial in advancing its development from bench to bedside.

• 139755-99-0(1-Methyl-3-propyl-1H-pyrazole-5-carboxylic acid)
• 194289-31-1(5-tert-butyl-1-methyl-1H-pyrazole-3-carboxylic acid)
• 1052668-36-6(1-methyl-5-(propan-2-yl)-1H-pyrazole-3-carboxylic acid)
• 957500-07-1(3-cyclopropyl-1-methyl-1H-pyrazole-5-carboxylic acid)
• 165744-15-0(5-Ethyl-1-methyl-1H-pyrazole-3-carboxylic acid)
• 769132-77-6(3-Isobutyl-1-methyl-1H-pyrazole-5-carboxylic acid)
• 175277-11-9(3-tert-butyl-1-methyl-1H-pyrazole-5-carboxylic acid)
• 26308-42-9(3-Ethyl-1-Methyl-1H-Pyrazole-5-Carboxylic Acid)
• 167408-66-4(methyl 1-methyl-3-(propan-2-yl)-1H-pyrazole-5-carboxylate)
• 956397-13-0(1-ethyl-3-(propan-2-yl)-1H-pyrazole-5-carboxylic acid)